Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Avacta Group (AIM: AVCT) preCISION data signals tumor selectivity index emerging as the new ADC battleground Avacta is not just challenging Enhertu. It is rewriting the metric the entire ADC industry will be diligenced on. Tumor selectivity is the new battleground. byVenkateshMay 10, 2026